The community is delayed by three days for non registered users.

Now on 1st page of my FInViz screener

SEMR--discovered this company. very interesting.

Semrush Holdings, Inc. develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally. The company enables companies to identify and reach the right audience for their content through the right channels. Its platform enables the company's customers to understand trends and act upon insights to enhance the online visibility, and drive traffic to their websites and social media pages, as well as online listings, distribute targeted content to their customers, and measure the digital marketing campaigns.

HAIN--my "RFK Jr get approved

Posted by shellson2 on 6th of Feb 2025 at 10:11 am

HAIN--my "RFK Jr get approved healthy food play" . Been crushed over past year+, may be due for a bounce back?

"We believe these data provide further validation of the RaniPill ®oral delivery platform across a wide variety of injectable obesity treatments. We are encouraged to see that delivery of semaglutide via the RaniPill ®capsule demonstrated comparable bioavailability, pharmacokinetics and weight loss to subcutaneous administration of semaglutide at the same dose," said Talat Imran, Chief Executive Officer of Rani Therapeutics. "The target product profile of semaglutide in the RaniPill ®capsule would be once-weekly oral administration of semaglutide therapy, which we believe may be more convenient for patients and could lead to improved adherence. Overall, the totality of the preclinical data we have generated in the obesity space demonstrating the successful delivery of both single and triagonist incretin therapies gives us confidence to continue building our obesity portfolio to unlock the true value of the RaniPill ®technology. Looking ahead, we are excited to begin our Phase 1 study for RT-114, Rani's GLP-1/GLP-2 dual agonist in partnership with ProGen this year."

RANI--very early stages for this

Posted by shellson2 on 6th of Feb 2025 at 09:38 am

RANI--very early stages for this company, but successful Phase 1 trial on Semeglatute in pill form. Considered the next holy grail format to weight loss. Again, a few years away in all likelihood.

Thx. More lift after hours. Serious mojo 

Analysts (some at least), call this a baby Plantir (I'm para-phrasing), but you get the idea...

Now up 25%

BBAI

ATOM, CRNC & BBAI held nice at close

Posted by shellson2 on 5th of Feb 2025 at 09:23 am

BBAI

Moving again this morning

PTCT--repost from Matt on 5/1. 

Cantor slaps $117 price target, upped from $79. FWIW

Continues to be a great

BFLY--heavy volume, up 9%

Posted by shellson2 on 4th of Feb 2025 at 12:27 pm

Continues to be a great call master.  Strong again today

Clawing  its way back...

BBAi--really moving today (halo effect from palantir)

BRBR--results were better than expected, but its selling off. Has had a good run. Monitoring

Thx

FUBO RDDT

Posted by shellson2 on 4th of Feb 2025 at 10:45 am

Thx

Steve--OSS on the move...

Posted by shellson2 on 4th of Feb 2025 at 09:51 am

Steve--OSS on the move...

HUBC--for the very speculative trader.

Posted by shellson2 on 4th of Feb 2025 at 08:53 am

HUBC--for the very speculative trader. 32mm Cap, minimal sales. The stock is approaching $1--(important for nasdaq listing requirements, etc.). Encourage members to read more about them and the niche they play within the cyber security field. 

FTNT—reports tomorrow AH’s (expected). I

Posted by shellson2 on 4th of Feb 2025 at 08:26 am

FTNT—reports tomorrow AH’s (expected). I like the set up. Strong chart.

Pause in place for Canada. GM up 2.6%

Newsletter

Subscribe to our email list for regular free market updates
as well as a chance to get coupons!